Post-Marketing Study to Assess the Effectiveness and Safety of RECARBRIO in Chinese Adult Patients With Limited or No Alternative Treatment Options for Susceptible Gram-Negative Bacterial Infections (MK-7655A-035)

ENCePP Code of conduct

Yes

Data sources

• Data sources (types):
  Drug prescriptions

  Electronic healthcare records (EHR)

  Laboratory tests and analyses

  Non-interventional study

  Other
• Data sources (types), other:
  Medical records (paper), microbiology reports, medication records related to RECARBRIO and concomitant systemic antibiotic therapy, and other relevant clinical documents.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No

Procedures

No information provided.